Aletho News

ΑΛΗΘΩΣ

Russian Disinformation to Undermine US Mass-Jabbing for Covid?

By Stephen Lendman | March 7, 2021

On Sunday, the Wall Street Journal cited an unnamed State Department Global Engagement Center official, saying Russian intelligence is trying to undermine confidence in US mass-jabbing for covid.

No evidence was cited like virtually always when Russia and other invented US enemies are accused of things they had nothing to do with.

Russia aside, there’s nothing remotely safe and effective about rushed to market, inadequately tested, experimental Pfizer and Moderna mRNA technology.

The same goes for J & J covid vaccine and AstraZeneca’s entry in Europe.

They’re all unapproved, granted emergency use authorization when no emergency exists.

Less than two months after mass-jabbing began, countless thousands suffered serious adverse events including deaths.

No one should be a mass-jabbing guinea pig for Pharma.

No one should risk their health and well-being so Pfizer, Moderna, and now Johnson & Johnson can cash in big on a bonanza of profits at the expense of individuals duped to believe they’ll be protected from what’s too hazardous to touch.

According to State Department disinformation, New Eastern Outlook, Oriental Review, News Front, and Rebel Inside truth-telling about mass-jabbing hazards is Russian propaganda.

According to the unnamed US official, “Russian intelligence services bear direct responsibility for using these four platforms to spread propaganda and lies (sic),” adding:

“We can say these outlets are directly linked to Russian intelligence services (sic).”

“They’re all foreign-owned, based outside of the United States.”

“They vary a lot in their reach, their tone, their audience, but they’re all part of the Russian propaganda and disinformation ecosystem (sic).”

According to the neocon/Russophobic Alliance for Securing Democracy that’s militantly hostile to the notion everywhere:

“The emphasis on denigrating Pfizer is likely due to its status as the first vaccine besides Sputnik V to see mass use, resulting in a greater potential threat to Sputnik’s market dominance.”

Kremlin spokesman Dmitry Peskov debunked the above fake news, saying:

“It’s nonsense. Russian special services have nothing to do with any criticism against vaccines.

“If we treat every negative publication against the Sputnik V vaccine as a result of efforts by American special services, then we will go crazy because we see it every day, every hour and in every Anglo-Saxon media.”

The Journal explained that the unnamed US official “didn’t provide specific evidence linking the publications to Russian intelligence” — because none exists like time and again earlier when phony accusations are made.

Unlike US rushed to market experimental drugs for mass-jabbing, introduction of Russia’s Sputnik V vaccine last summer followed over 20 years of vaccine research, according to Sechenov University’s Institute for Translational Medicine and Biotechnology director Vadim Tarasov.

Technology used to develop Sputnik V is based upon adenovirus, the common cold.

Tarasov explained that the vaccine may not entirely stop covid from spreading. It’ll make symptoms milder, he said, adding:

“We can really talk about a breakthrough as our country has shown itself to be one of the leaders in the global pharmaceutical industry due to the fact that it has retained and developed new competencies in drug development.”

There’s no ambiguity about the health hazards of experimental US drugs for mass-jabbing.

Using them as directed risks serious self-inflicted harm or death — why it’s crucial to avoid them.

March 7, 2021 Posted by | Fake News, Mainstream Media, Warmongering, Russophobia | | 1 Comment

COVID-19: RDIF Points to Absence of Long-Term Studies on Vaccines Based on Monkey Adenoviral Vectors

By Aleksandra Serebriakova – Sputnik – 09.09.2020

The third round of trials for the AstraZeneca anti-COVID-19 drug is now on pause over “potentially unexplained illness” in a participant in the UK. On 11 August, Russia registered its own Sputnik V anti-coronavirus vaccine, which is said to have been developed in a different way.

The Russian Direct Investment Fund (RDIF) the investor which has funded the development of Russia’s Sputnik V anti-coronavirus vaccine, could not comment on the halt of AstraZeneca trials, it said in a statement.

However, RDIF pointed out that the fund’s CEO Kirill Dmitriev had previously discussed the differences between the human adenoviral vector-based platform used in Russia’s Sputnik V vaccine and those used by some of their international colleagues, that rely on “novel unproven technologies such as monkey adenoviral vectors or mRNA”.

“The safety of the human adenoviral vector used in Sputnik V has been proven over decades in over 250 clinical studies, as human adenovirus has been shown to be the safest vaccine delivery mechanism and the most ‘organic for humans’, as human adenovirus has coexisted with humans for over 100,000 years,” RFID said.

Meanwhile, “mRNA and monkey adenoviral vector-based platforms have not been studied over a long period of time,” RDIF CEO Dmitriev pointed out this Tuesday.

Commenting on the so-called “pledge of safety” earlier voiced by the CEOs of AstraZeneca, BioNTech, GlaxoSmithKline, Johnson & Johnson, Merck, Moderna, Novavax, Pfizer and Sanofi in relation to the development of the first COVID-19 vaccines, Dmitriev stressed that this plea was “insufficient” as it did not “discuss the lack of long-term studies on the carcinogenic effects and impact on fertility of newly-developed vaccine technologies”.

“Since some of the companies developing these vaccines have taken the ‘pledge of safety’, we would like to stress that public health and safety requires not only short-term evidence of a lack of serious adverse effects, but also the safety and efficacy proved by the results of long-term studies,” Dmitriev added.

AstraZeneca COVID-19 Vaccine Trials on Pause

It was revealed this week that the third round of trials for the AstraZeneca anti-COVID-19 vaccine has been halted due to a “potentially unexplained illness” which had developed in a participant in the United Kingdom, without further specifications about the nature of possible side effects. The vaccine in question was developed in partnership with Oxford University and has reportedly involved around 30,000 participants in the UK, US, Brazil and South Africa. AstraZeneca described the pause as “routine” so as to allow for a “standard review process” of “safety data”.

Russia’s First Anti-Coronavirus Vaccine

On 11 August, Russia registered the world’s first vaccine against COVID-19, called Sputnik V, which was developed by the Gamaleya National Research Centre of Epidemiology and Microbiology and the RDIF after several rounds of clinical trials. On Monday, the vaccine was made available to the public.

According to RDIF, Russia has now received requests for 1 billion doses of the vaccine; at least 20 countries, including the UAE, Saudi Arabia, Indonesia, Philippines, Mexico, Brazil and India, have expressed an interest in obtaining Sputnik V.

September 9, 2020 Posted by | Aletho News | , , , , , , , , , | Leave a comment